Skip to main content

Advertisement

Log in

MRI of the stomach: a pictorial review with a focus on oncological applications and gastric motility

  • Pictorial Essay
  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

The purpose of this pictorial review is to demonstrate gastric pathology seen on magnetic resonance imaging (MRI) and discuss the essential MRI sequences for the evaluation of benign and malignant gastric pathologies. Common tumors of the stomach, polyposis syndromes, iatrogenic conditions, as well as other conditions of the stomach will be reviewed. The utility of MRI in the evaluation of patients with gastric malignancies and disorders of gastric motility will also be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17
Fig. 18
Fig. 19
Fig. 20
Fig. 21
Fig. 22
Fig. 23
Fig. 24

Similar content being viewed by others

References

  1. Brown G, Radcliffe AG, Newcombe RG, et al. (2003) Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90:355–364. doi:10.1002/bjs.4034

    CAS  PubMed  Google Scholar 

  2. Lin C, Luciani A, Itti E, et al. (2010) Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 20:2027–2038. doi:10.1007/s00330-010-1758-y

    PubMed  Google Scholar 

  3. Onur MR, Ozturk F, Aygun C, et al. (2012) Role of the apparent diffusion coefficient in the differential diagnosis of gastric wall thickening. J Magn Reson Imaging 36:672–677. doi:10.1002/jmri.23698

    PubMed  Google Scholar 

  4. Gong N-J, Wong C-S, Chu Y-C, Gu J (2013) Treatment response monitoring in patients with gastrointestinal stromal tumor using diffusion-weighted imaging: preliminary results in comparison with positron emission tomography/computed tomography. NMR Biomed 26:185–192. doi:10.1002/nbm.2834

    PubMed  Google Scholar 

  5. Oi H, Matsushita M, Murakami T, Nakamura H (1997) Dynamic MR imaging for extraserosal invasion of advanced gastric cancer. Abdom Imaging 22:35–40

    CAS  PubMed  Google Scholar 

  6. Giganti F, De Cobelli F, Canevari C, et al. (2013) Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade. J Magn Reson Imaging . doi:10.1002/jmri.24464

    PubMed  Google Scholar 

  7. Wong CS, Gong N, Chu Y-C, et al. (2012) Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV. Eur J Radiol 81:2122–2126. doi:10.1016/j.ejrad.2011.09.003

    PubMed  Google Scholar 

  8. Hersh MR, Choi J, Garrett C, Clark R (2005) Imaging gastrointestinal stromal tumors. Cancer Control 12:111–115

    PubMed  Google Scholar 

  9. Seevaratnam R, Cardoso R, McGregor C, et al. (2012) How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer 15(Suppl 1):S3–S18. doi:10.1007/s10120-011-0069-6

    PubMed  Google Scholar 

  10. Schmidt S, Dunet V, Koehli M, et al. (2013) Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT. Acta Radiol 54:837–842. doi:10.1177/0284185113485732

    PubMed  Google Scholar 

  11. Wang CK, Kuo YT, Liu GC, et al. (2000) Dynamic contrast-enhanced subtraction and delayed MRI of gastric tumors: radiologic–pathologic correlation. J Comput Assist Tomogr 24:872–877

    CAS  PubMed  Google Scholar 

  12. Bilecen D, Scheffler K, Seifritz E, et al. (2000) Hydro-MRI for the visualization of gastric wall motility using RARE magnetic resonance imaging sequences. Abdom Imaging 25:30–34

    CAS  PubMed  Google Scholar 

  13. Kim AY, Han JK, Kim TK, et al. (2000) MR imaging of advanced gastric cancer: comparison of various MR pulse sequences using water and gadopentetate dimeglumine as oral contrast agents. Abdom Imaging 25:7–13

    CAS  PubMed  Google Scholar 

  14. Lohan DG, Walsh SM, Allen RH, et al. (2006) Potential role of calogen as an oral contrast medium in the evaluation of the gastric wall at MRI. Eur Radiol 16:2828–2833. doi:10.1007/s00330-006-0347-6

    PubMed  Google Scholar 

  15. Kraus BB, Rappaport DC, Ros PR, Torres GM (1994) Evaluation of oral contrast agents for abdominal magnetic resonance imaging. Magn Reson Imaging 12:847–858

    CAS  PubMed  Google Scholar 

  16. Fidler JL, Guimaraes L, Einstein DM (2009) MR imaging of the small bowel. Radiographics 29:1811–1825. doi:10.1148/rg.296095507

    PubMed  Google Scholar 

  17. Grand DJ, Beland M, Harris A (2013) Magnetic resonance enterography. Radiol Clin North Am 51:99–112. doi:10.1016/j.rcl.2012.09.007

    PubMed  Google Scholar 

  18. Masselli G, Gualdi G (2012) MR imaging of the small bowel. Radiology 264:333–348. doi:10.1148/radiol.12111658

    PubMed  Google Scholar 

  19. Schwizer W, Steingoetter A, Fox M (2006) Magnetic resonance imaging for the assessment of gastrointestinal function. Scand J Gastroenterol 41:1245–1260. doi:10.1080/00365520600827188

    PubMed  Google Scholar 

  20. Ang D (2011) Measurement of gastric accommodation: a reappraisal of conventional and emerging modalities. Neurogastroenterol Motil 23:287–291. doi:10.1111/j.1365-2982.2011.01690.x

    CAS  PubMed  Google Scholar 

  21. De Zwart IM, Mearadji B, Lamb HJ, et al. (2002) Gastric motility: comparison of assessment with real-time MR imaging or barostat measurement initial experience. Radiology 224:592–597. doi:10.1148/radiol.2242011412

    PubMed  Google Scholar 

  22. Waseem S, Moshiree B, Draganov PV (2009) Gastroparesis: current diagnostic challenges and management considerations. World J Gastroenterol 15:25–37

    PubMed Central  PubMed  Google Scholar 

  23. Camilleri M (2006) New imaging in neurogastroenterology: an overview. Neurogastroenterol Motil 18:805–812. doi:10.1111/j.1365-2982.2006.00786.x

    CAS  PubMed  Google Scholar 

  24. Sarnelli G, Vos R, Cuomo R, et al. (2001) Reproducibility of gastric barostat studies in healthy controls and in dyspeptic patients. Am J Gastroenterol 96:1047–1053. doi:10.1111/j.1572-0241.2001.03520.x

    CAS  PubMed  Google Scholar 

  25. Ajaj W, Lauenstein T, Papanikolaou N, et al. (2004) Real-time high-resolution MRI for the assessment of gastric motility: pre- and postpharmacological stimuli. J Magn Reson Imaging 19:453–458. doi:10.1002/jmri.20029

    PubMed  Google Scholar 

  26. Kwiatek MA, Steingoetter A, Pal A, et al. (2006) Quantification of distal antral contractile motility in healthy human stomach with magnetic resonance imaging. J Magn Reson Imaging 24:1101–1109. doi:10.1002/jmri.20738

    PubMed  Google Scholar 

  27. Carbone SF, Tanganelli I, Capodivento S, et al. (2010) Magnetic resonance imaging in the evaluation of the gastric emptying and antral motion: feasibility and reproducibility of a fast not invasive technique. Eur J Radiol 75:212–214. doi:10.1016/j.ejrad.2009.04.071

    PubMed  Google Scholar 

  28. Baba S, Sasaki A, Nakajima J, et al. (2009) Assessment of gastric motor function by cine magnetic resonance imaging. J Gastroenterol Hepatol 24:1401–1406. doi:10.1111/j.1440-1746.2009.05891.x

    PubMed  Google Scholar 

  29. Feinle C, Kunz P, Boesiger P, et al. (1999) Scintigraphic validation of a magnetic resonance imaging method to study gastric emptying of a solid meal in humans. Gut 44:106–111

    PubMed Central  CAS  PubMed  Google Scholar 

  30. Borovicka J, Lehmann R, Kunz P, et al. (1999) Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride. Am J Gastroenterol 94:2866–2873. doi:10.1111/j.1572-0241.1999.01392.x

    CAS  PubMed  Google Scholar 

  31. Stabile BE, Morrow DJ, Passaro E (1984) The gastrinoma triangle: operative implications. Am J Surg 147:25–31

    CAS  PubMed  Google Scholar 

  32. Roy PK, Venzon DJ, Shojamanesh H, et al. (2000) Zollinger–Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore) 79:379–411

    CAS  Google Scholar 

  33. Banasch M, Schmitz F (2007) Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors. Wien Klin Wochenschr 119:573–578. doi:10.1007/s00508-007-0884-2

    CAS  PubMed  Google Scholar 

  34. Berna MJ, Hoffmann KM, Serrano J, et al. (2006) Serum gastrin in Zollinger–Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Medicine (Baltimore) 85:295–330. doi:10.1097/01.md.0000236956.74128.76

    CAS  Google Scholar 

  35. Noone TC, Hosey J, Firat Z, Semelka RC (2005) Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metab 19:195–211. doi:10.1016/j.beem.2004.11.013

    PubMed  Google Scholar 

  36. Balci NC, Semelka RC (2001) Radiologic features of cystic, endocrine and other pancreatic neoplasms. Eur J Radiol 38:113–119. doi:10.1016/S0720-048X(01)00296-0

    CAS  PubMed  Google Scholar 

  37. Semelka RC, Custodio CM, Cem Balci N, Woosley JT (2000) Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reson Imaging 11:141–148

    CAS  PubMed  Google Scholar 

  38. Lambrecht NWG (2011) Ménétrier’s disease of the stomach: a clinical challenge. Curr Gastroenterol Rep 13:513–517. doi:10.1007/s11894-011-0222-8

    PubMed  Google Scholar 

  39. Coffey RJ, Washington MK, Corless CL, Heinrich MC (2007) Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest 117:70–80. doi:10.1172/JCI30491

    PubMed Central  CAS  PubMed  Google Scholar 

  40. Sonavane SK, Menias CO, Kantawala KP, et al. (2012) Laparoscopic adjustable gastric banding: what radiologists need to know. Radiographics 32:1161–1178. doi:10.1148/rg.324115177

    PubMed  Google Scholar 

  41. Peternac D, Hauser R, Weber M, Schöb O (2001) The effects of laparoscopic adjustable gastric banding on the proximal pouch and the esophagus. Obes Surg 11:76–86. doi:10.1381/096089201321454150

    CAS  PubMed  Google Scholar 

  42. Scheirey CD, Scholz FJ, Shah PC, et al. (2013) Radiology of the laparoscopic Roux-en-Y gastric bypass procedure: conceptualization and precise interpretation of results. Radiographics 26:1355–1371. doi:10.1148/rg.265055123

    Google Scholar 

  43. Chen H (2010) Illustrative handbook of general surgery. New York: Springer. doi:10.1007/978-1-84882-089-0

  44. Sarin SK, Lahoti D, Saxena SP, et al. (1992) Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 16:1343–1349. doi:10.1002/hep.1840160607

    CAS  PubMed  Google Scholar 

  45. Ryan BM, Stockbrugger RW, Ryan JM (2004) A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology 126:1175–1189

    PubMed  Google Scholar 

  46. Okuda K, Yasumoto M, Goto A, Kunisaki T (1973) Endoscopic observations of gastric varices. Am J Gastroenterol 60:357–365

    CAS  PubMed  Google Scholar 

  47. Ono N, Toyonaga A, Nishimura H, et al. (1997) Evaluation of magnetic resonance angiography on portosystemic collaterals in cirrhotic patients. Am J Gastroenterol 92:1515–1519

    CAS  PubMed  Google Scholar 

  48. Kin H, Kubota Y, Tsuji K, et al. (1998) MR imaging in the evaluation of the therapeutic effect of B-RTO for gastric varices. Hepatogastroenterology 45:677–683

    CAS  PubMed  Google Scholar 

  49. Willmann JK, Bauerfeind P, Boehm T, et al. (2003) Contrast-enhanced MR angiography for differentiation between perigastric and submucosal gastric fundal varices. Rofo 175:507–514. doi:10.1055/s-2003-38440

    CAS  PubMed  Google Scholar 

  50. Kodera R, Otsuka F, Inagaki K, et al. (2007) Gastric diverticulum simulating left adrenal incidentaloma in a hypertensive patient. Endocr J 54:969–974

    PubMed  Google Scholar 

  51. Araki A, Shinohara M, Yamakawa J, et al. (2006) Gastric diverticulum preoperatively diagnosed as one of two left adrenal adenomas. Int J Urol 13:64–66. doi:10.1111/j.1442-2042.2006.01236.x

    PubMed  Google Scholar 

  52. Abraham SC, Singh VK, Yardley JH, Wu TT (2001) Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol 25:500–507

    CAS  PubMed  Google Scholar 

  53. Jain R, Chetty R (2009) Gastric hyperplastic polyps: a review. Dig Dis Sci 54:1839–1846. doi:10.1007/s10620-008-0572-8

    PubMed  Google Scholar 

  54. Morais DJ, Yamanaka A, Zeitune JMR, Andreollo NA (2007) Gastric polyps: a retrospective analysis of 26,000 digestive endoscopies. Arq Gastroenterol 44:14–17

    PubMed  Google Scholar 

  55. Choi YS, Suh JP, Lee IT, et al. (2012) Regression of giant pseudopolyps in inflammatory bowel disease. J Crohns Colitis 6:240–243. doi:10.1016/j.crohns.2011.08.007

    CAS  PubMed  Google Scholar 

  56. Giardiello FM, Trimbath JD (2006) Peutz–Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 4:408–415. doi:10.1016/j.cgh.2005.11.005

    PubMed  Google Scholar 

  57. Bianchi LK, Burke CA, Bennett AE, et al. (2008) Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 6:180–185. doi:10.1016/j.cgh.2007.11.018

    PubMed  Google Scholar 

  58. Half E, Bercovich D, Rozen P (2009) Familial adenomatous polyposis. Orphanet J Rare Dis 4:22. doi:10.1186/1750-1172-4-22

    PubMed Central  PubMed  Google Scholar 

  59. Tulchinsky H, Keidar A, Strul H, et al. (2005) Extracolonic manifestations of familial adenomatous polyposis after proctocolectomy. Arch Surg 140:159–63; discussion 164. doi:10.1001/archsurg.140.2.159

  60. Arnold M, Moore SP, Hassler S, et al. (2014) The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut 63:64–71. doi:10.1136/gutjnl-2013-305033

    PubMed  Google Scholar 

  61. Parkin D, Bray F, Devesa S (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:4–66. doi:10.1016/S0959-8049(01)00267-2

    Google Scholar 

  62. Mastoraki A, Papanikolaou IS, Sakorafas G, Safioleas M (2009) Facing the challenge of managing linitis plastica—review of the literature. Hepatogastroenterology 56:1773–1778

    PubMed  Google Scholar 

  63. Kang BC, Kim JH, Kim KW, et al. (2000) Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer: correlation with the histopathology. Abdom Imaging 25:14–24

    CAS  PubMed  Google Scholar 

  64. Liu S, He J, Guan W, et al. (2013) Added value of diffusion-weighted MR imaging to T2-weighted and dynamic contrast-enhanced MR imaging in T staging of gastric cancer. Clin Imaging . doi:10.1016/j.clinimag.2013.12.001

    Google Scholar 

  65. Hallinan JTPD, Venkatesh SK (2013) Gastric carcinoma: imaging diagnosis, staging and assessment of treatment response. Cancer Imaging 13:212–227. doi:10.1102/1470-7330.2013.0023

    PubMed Central  PubMed  Google Scholar 

  66. Muntean V, Mihailov A, Iancu C, et al. (2009) Staging laparoscopy in gastric cancer. Accuracy and impact on therapy. J Gastrointest Liver Dis 18:189–195

    Google Scholar 

  67. Dixon M, Cardoso R, Tinmouth J, et al. (2013) What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel. Gastric Cancer. doi:10.1007/s10120-013-0262-x

  68. Matsushita M, Oi H, Murakami T, et al. (1994) Extraserosal invasion in advanced gastric cancer: evaluation with MR imaging. Radiology 192:87–91. doi:10.1148/radiology.192.1.8208971

    CAS  PubMed  Google Scholar 

  69. Coburn N, Seevaratnam R, Paszat L, et al. (2014) Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg 259:102–108. doi:10.1097/SLA.0b013e318288dd2b

    PubMed  Google Scholar 

  70. Van Cutsem E, Dicato M, Geva R, et al. (2011) The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol 22(Suppl 5):v1–v9. doi:10.1093/annonc/mdr284

    PubMed  Google Scholar 

  71. D’Elia F, Zingarelli A, Palli D, Grani M (2000) Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol 10:1877–1885

    PubMed  Google Scholar 

  72. Kim SH, Kim JJ, Lee JS, et al. (2013) Preoperative N staging of gastric cancer by stomach protocol computed tomography. J Gastric Cancer 13:149–156. doi:10.5230/jgc.2013.13.3.149

    PubMed Central  PubMed  Google Scholar 

  73. Stabile Ianora AA, Pedote P, Scardapane A, et al. (2003) Preoperative staging of gastric carcinoma with multidetector spiral CT. Radiol Med 106:467–480

    PubMed  Google Scholar 

  74. Cheng J, Wang Y, Deng J, et al. (2013) Discrimination of metastatic lymph nodes in patients with gastric carcinoma using diffusion-weighted imaging. J Magn Reson Imaging 37:1436–1444. doi:10.1002/jmri.23925

    PubMed  Google Scholar 

  75. Jang KM, Kim SH, Lee SJ, et al. (2014) Upper abdominal gadoxetic acid-enhanced and diffusion-weighted MRI for the detection of gastric cancer: comparison with two-dimensional multidetector row CT. Clin Radiol . doi:10.1016/j.crad.2014.03.017

    Google Scholar 

  76. Joo I, Lee JM, Kim JH, et al. (2014) Prospective comparison of 3T MRI with diffusion-weighted imaging and MDCT for the preoperative TNM staging of gastric cancer. J Magn Reson Imaging . doi:10.1002/jmri.24586

    Google Scholar 

  77. Liu S, He J, Guan W, et al. (2014) Preoperative T staging of gastric cancer: comparison of diffusion- and T2-weighted magnetic resonance imaging. J Comput Assist Tomogr . doi:10.1097/RCT.0000000000000090

    Google Scholar 

  78. Satoh A, Shuto K, Okazumi S, et al. (2010) Role of perfusion CT in assessing tumor blood flow and malignancy level of gastric cancer. Dig Surg 27:253–260. doi:10.1159/000288703

    PubMed  Google Scholar 

  79. Yao J, Yang Z, Chen H, et al. (2011) Gastric adenocarcinoma: can perfusion CT help to noninvasively evaluate tumor angiogenesis? Abdom Imaging 36:15–21. doi:10.1007/s00261-010-9609-5

    PubMed  Google Scholar 

  80. Akisik MF, Sandrasegaran K, Bu G, et al. (2010) Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy. Radiology 256:441–449. doi:10.1148/radiol.10091733

    PubMed  Google Scholar 

  81. De Lussanet QG, Backes WH, Griffioen AW, et al. (2005) Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol Phys 63:1309–1315. doi:10.1016/j.ijrobp.2005.04.052

    PubMed  Google Scholar 

  82. Esserman L, Hylton N, George T, Weidner N (1999) Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 5:13–21

    PubMed  Google Scholar 

  83. Yamashita Y, Baba T, Baba Y, et al. (2000) Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 216:803–809. doi:10.1148/radiology.216.3.r00se07803

    CAS  PubMed  Google Scholar 

  84. Al-Akwaa AM, Siddiqui N, Al-Mofleh IA (2004) Primary gastric lymphoma. World J Gastroenterol 10:5–11

    PubMed  Google Scholar 

  85. Weingrad DN, Decosse JJ, Sherlock P, et al. (1982) Primary gastrointestinal lymphoma: a 30-year review. Cancer 49:1258–1265

    CAS  PubMed  Google Scholar 

  86. Warrick J, Luo J, Robirds D, et al. (2012) Gastrointestinal lymphomas in a North American population: clinicopathologic features from one major Central-Midwestern United States tertiary care medical center. Diagn Pathol 7:76. doi:10.1186/1746-1596-7-76

    PubMed Central  PubMed  Google Scholar 

  87. Lewin KJ, Ranchod M, Dorfman RF (1978) Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer 42:693–707

    CAS  PubMed  Google Scholar 

  88. Aozasa K, Tsujimoto M, Inoue A, et al. (1985) Primary gastrointestinal lymphoma. A clinicopathologic study of 102 patients. Oncology 42:97–103

    CAS  PubMed  Google Scholar 

  89. Loehr WJ, Mujahed Z, Zahn FD, et al. (1969) Primary lymphoma of the gastrointestinal tract: a review of 100 cases. Ann Surg 170:232–238

    PubMed Central  CAS  PubMed  Google Scholar 

  90. Danzon A, Belot A, Maynadié M, et al. (2009) Incidence and survival of gastric non-Hodgkin’s lymphoma: a population-based study from the Association of the French Cancer Registries (FRANCIM). Acta Oncol 48:977–983. doi:10.1080/02841860903032825

    PubMed  Google Scholar 

  91. Cho KC, Baker SR, Alterman DD, et al. (1996) Transpyloric spread of gastric tumors: comparison of adenocarcinoma and lymphoma. AJR Am J Roentgenol 167:467–469. doi:10.2214/ajr.167.2.8686627

    CAS  PubMed  Google Scholar 

  92. Meyers MA, Katzen B, Alonso DR (1975) Transpyloric extension to duodenal bulb in gastric lymphoma. Radiology 115:575–580. doi:10.1148/15.3.575

    CAS  PubMed  Google Scholar 

  93. Hricak H, Thoeni RF, Margulis AR, et al. (1980) Extension of gastric lymphoma into the esophagus and duodenum. Radiology 135:309–312. doi:10.1148/radiology.135.2.7367617

    CAS  PubMed  Google Scholar 

  94. Chou CK, Chen LT, Sheu RS, et al. (1994) MRI manifestations of gastrointestinal lymphoma. Abdom Imaging 19:495–500

    CAS  PubMed  Google Scholar 

  95. Lin C, Itti E, Luciani A, et al. (2010) Whole-body diffusion-weighted imaging in lymphoma. Cancer Imaging 10(Spec no):S172–S178. doi:10.1102/1470-7330.2010.9029

    PubMed Central  PubMed  Google Scholar 

  96. Avcu S, Arslan H, Unal O, et al. (2012) The role of diffusion-weighted MR imaging and ADC values in the diagnosis of gastric tumors. JBR-BTR 95:1–5

    CAS  PubMed  Google Scholar 

  97. Padhani AR, Koh D-M, Collins DJ (2011) Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 261:700–718. doi:10.1148/radiol.11110474

    PubMed  Google Scholar 

  98. Wu X, Kellokumpu-Lehtinen P-L, Pertovaara H, et al. (2011) Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma–a pilot study: comparison with 2-deoxy-2-fluoro-d-glucose-positron emission tomography/computed tomography. NMR Biomed 24:1181–1190. doi:10.1002/nbm.1689

    CAS  PubMed  Google Scholar 

  99. Lin C, Luciani A, Itti E, et al. (2012) Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma. Cancer Imaging 12:403–408. doi:10.1102/1470-7330.2012.9048

    PubMed Central  PubMed  Google Scholar 

  100. Nishida T, Hirota S (2000) Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 15:1293–1301

    CAS  PubMed  Google Scholar 

  101. Miettinen M, Lasota J (2001) Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438:1–12. doi:10.1007/s004280000338

    CAS  PubMed  Google Scholar 

  102. Nowain A, Bhakta H, Pais S, et al. (2005) Gastrointestinal stromal tumors: clinical profile, pathogenesis, treatment strategies and prognosis. J Gastroenterol Hepatol 20:818–824. doi:10.1111/j.1440-1746.2005.03720.x

    PubMed  Google Scholar 

  103. Burkill GJC, Badran M, Al-Muderis O, et al. (2003) Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 226:527–532. doi:10.1148/radiol.2262011880

    PubMed  Google Scholar 

  104. DeMatteo RP, Lewis JJ, Leung D, et al. (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58

    PubMed Central  CAS  PubMed  Google Scholar 

  105. Carney JA (1999) Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc 74:543–552. doi:10.4065/74.6.543

    CAS  PubMed  Google Scholar 

  106. Darnell A, Dalmau E, Pericay C, et al. (2006) Gastrointestinal stromal tumors. Abdom Imaging 31:387–399. doi:10.1007/s00261-004-0092-8

    CAS  PubMed  Google Scholar 

  107. Lau S, Tam KF, Kam CK, et al. (2004) Imaging of gastrointestinal stromal tumour (GIST). Clin Radiol 59:487–498. doi:10.1016/j.crad.2003.10.018

    CAS  PubMed  Google Scholar 

  108. Tateishi U, Miyake M, Maeda T, et al. (2006) CT and MRI findings in KIT-weak or KIT-negative atypical gastrointestinal stromal tumors. Eur Radiol 16:1537–1543. doi:10.1007/s00330-005-0091-3

    PubMed  Google Scholar 

  109. Song T, Shen J, Guo H, et al. (2007) Imaging and pathological features of gastrointestinal stromal tumors. Zhonghua Zhong Liu Za Zhi 29:386–390

    PubMed  Google Scholar 

  110. Martin DR, Danrad R, Herrmann K, et al. (2005) Magnetic resonance imaging of the gastrointestinal tract. Top Magn Reson Imaging 16:77–98

    PubMed  Google Scholar 

  111. Marcos HB, Semelka RC (1999) Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences. J Magn Reson Imaging 10:950–960

    CAS  PubMed  Google Scholar 

  112. Verweij J, van Oosterom A, Blay J-Y, et al. (2003) Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Eur J Cancer 39:2006–2011. doi:10.1016/S0959-8049(02)00836-5

    CAS  PubMed  Google Scholar 

  113. Demetri GD, von Mehren M, Blanke CD, et al. (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–480. doi:10.1056/NEJMoa020461

    CAS  PubMed  Google Scholar 

  114. Holdsworth CH, Badawi RD, Manola JB, et al. (2007) CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor. AJR Am J Roentgenol 189:W324–W330. doi:10.2214/AJR.07.2496

    PubMed  Google Scholar 

  115. Tang L, Zhang X-P, Sun Y-S, et al. (2011) Gastrointestinal stromal tumors treated with imatinib mesylate: apparent diffusion coefficient in the evaluation of therapy response in patients. Radiology 258:729–738. doi:10.1148/radiol.10100402

    PubMed  Google Scholar 

  116. Choi H (2008) Response evaluation of gastrointestinal stromal tumors. Oncologist 13(Suppl 2):4–7. doi:10.1634/theoncologist.13-S2-4

    PubMed  Google Scholar 

  117. Sandrasegaran K, Rajesh A, Rushing DA, et al. (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15:1407–1414. doi:10.1007/s00330-005-2647-7

    PubMed  Google Scholar 

  118. Antoch G, Herrmann K, Heusner TA, Buck AK (2009) Imaging procedures for gastrointestinal stromal tumors. Radiologe 49:1109–1116. doi:10.1007/s00117-009-1852-9

    CAS  PubMed  Google Scholar 

  119. Shankar S, Dundamadappa SK, Karam AR, et al. (2009) Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy. Acta Radiol 50:837–844. doi:10.1080/02841850903059423

    CAS  PubMed  Google Scholar 

  120. Stroszczynski C, Jost D, Reichardt P, et al. (2005) Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI. Eur Radiol 15:2448–2456. doi:10.1007/s00330-005-2867-x

    PubMed  Google Scholar 

  121. de Campoli PMO, Ejima FH, Cardoso DMM, et al. (2006) Metastatic cancer to the stomach. Gastric Cancer 9:19–25. doi:10.1007/s10120-005-0352-5

  122. De Palma GD, Masone S, Rega M, et al. (2006) Metastatic tumors to the stomach: clinical and endoscopic features. World J Gastroenterol 12:7326–7328

    PubMed Central  PubMed  Google Scholar 

  123. Oda Kondo H, Yamao T, et al. (2001) Metastatic tumors to the stomach: analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases. Endoscopy 33:507–510. doi:10.1055/s-2001-14960

    CAS  PubMed  Google Scholar 

  124. Menuck LS, Amberg JR (1975) Metastatic disease involving the stomach. Am J Dig Dis 20:903–913

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arman Sheybani.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sheybani, A., Menias, C.O., Luna, A. et al. MRI of the stomach: a pictorial review with a focus on oncological applications and gastric motility. Abdom Imaging 40, 907–930 (2015). https://doi.org/10.1007/s00261-014-0251-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-014-0251-5

Keywords

Navigation